MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$53,205K
Free Cash flow
$176,573K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Depreciation and amortization
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Repurchase of common stock
Purchases of marketable securiti...
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
151,569
124,302
140,594
118,966
Bargain purchase gain
0
1,118
3,343
3,800
Acquired in-process research and development
-
-
0
-
Depreciation and amortization
69,499
69,856
69,011
71,126
Amortization of premiums on marketable securities
-
-
-
53
Provision for excess and obsolete inventory
4,835
4,960
6,131
5,055
Amortization of inventory fair value step-up
-
-
-
6,958
Amortization of 2025 notes fair value step-up
-
-
-
0
Amortization of acquisition accounting fair value step up
0
0
26,112
-
Stock-based compensation expense
13,383
12,617
11,418
11,538
Allowance for expected credit losses
5,121
5,277
4,912
757
Change in fair value of business acquisition liabilities
9,707
6,352
10,794
-2,721
Change in deferred income taxes
7,786
7,962
18,100
41,761
(gain)/loss on disposal of assets, net
-3,109
-2,449
-4,087
-2,307
Payment of business acquisition-related liabilities
323
2,273
593
661
Net (gain)/loss from foreign currency adjustment
120
98
-27,212
14,621
Accounts receivable
13,812
13,399
64,153
8,424
Inventories
27,900
16,651
178
5,698
Prepaid expenses and other assets
7,401
-6,942
-17,821
7,541
Accounts payable
307
5,082
9,141
3,431
Accrued expenses and other liabilities
-11,070
-24,668
8,775
39,283
Income taxes payable/receivable
4,811
14,576
7,085
-19,310
Net cash provided by/(used in) operating activities
209,741
202,364
248,587
249,695
Purchases of marketable securities
107,620
146,393
70,422
37,109
Maturities of marketable securities
-
-
5,250
0
Sales of marketable securities
-
-
0
0
Sales and maturities of marketable securities
13,240
8,243
-
-
Purchases of property and equipment
33,168
39,615
46,197
35,817
Acquisition of businesses, net of cash acquired and purchases of intangible and other assets
1,500
4,909
0
0
Acquisition of intangible assets
-
-
80
4,666
Proceeds from credit facility
-
-
-
20,000
Repayments of borrowings from credit facility
-
-
-
20,000
Net cash provided by/(used in) investing activities
-129,048
-182,674
-111,449
-75,842
Payment of business acquisition-related liabilities
9,396
4,324
4,332
3,376
Net proceeds from exercise of stock options
10,971
25,961
62,758
11,079
Payments related to tax withholdings for share-based compensation
13
3,440
211
-255
Repurchase of common stock
136,058
0
45,000
40,000
Repayment of senior convertible notes
0
0
0
449,985
Net cash provided by/(used in) financing activities
-134,496
18,197
13,215
-32,042
Effect of foreign exchange rates on cash
598
-3,093
4,034
512
Net increase/(decrease) in cash and cash equivalents
-53,205
34,794
154,387
142,323
Cash and cash equivalents at beginning of period
560,950
526,156
371,769
784,438
Cash and cash equivalents at end of period
507,745
560,950
526,156
371,769
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$151,569K
(-45.54%↓ Y/Y)
Depreciation and
amortization
$69,499K
(-49.16%↓ Y/Y)
Stock-based compensation
expense
$13,383K
(-50.11%↓ Y/Y)
Change in fair value of
business acquisition...
$9,707K
(80.13%↑ Y/Y)
Change in deferred
income taxes
$7,786K
(118.88%↑ Y/Y)
Allowance for expected
credit losses
$5,121K
(12.45%↑ Y/Y)
Provision for excess and
obsolete inventory
$4,835K
(-55.78%↓ Y/Y)
Income taxes
payable/receivable
$4,811K
(112.46%↑ Y/Y)
(gain)/loss on disposal of
assets, net
-$3,109K
(49.29%↑ Y/Y)
Accounts payable
$307K
(107.52%↑ Y/Y)
Net (gain)/loss
from foreign...
$120K
(-98.94%↓ Y/Y)
Net cash provided
by/(used in) operating...
$209,741K
(-17.80%↓ Y/Y)
Effect of foreign
exchange rates on cash
$598K
(-96.66%↓ Y/Y)
Canceled cashflow
$60,506K
Net
increase/(decrease) in cash and cash...
-$53,205K
(90.41%↑ Y/Y)
Canceled cashflow
$210,339K
Net proceeds from
exercise of stock options
$10,971K
(-31.09%↓ Y/Y)
Sales and maturities
of marketable...
$13,240K
Inventories
$27,900K
(138.01%↑ Y/Y)
Accounts receivable
$13,812K
(167.72%↑ Y/Y)
Accrued expenses and
other liabilities
-$11,070K
(20.02%↑ Y/Y)
Prepaid expenses and
other assets
$7,401K
(968.66%↑ Y/Y)
Payment of business
acquisition-related liabilities
$323K
(-97.95%↓ Y/Y)
Net cash provided
by/(used in) financing...
-$134,496K
(79.63%↑ Y/Y)
Canceled cashflow
$10,971K
Net cash provided
by/(used in) investing...
-$129,048K
(23.06%↑ Y/Y)
Canceled cashflow
$13,240K
Repurchase of common stock
$136,058K
(-36.85%↓ Y/Y)
Payment of business
acquisition-related liabilities
$9,396K
(19.48%↑ Y/Y)
Payments related to tax
withholdings for share-based...
$13K
(-99.56%↓ Y/Y)
Purchases of marketable
securities
$107,620K
(6049.71%↑ Y/Y)
Purchases of property and
equipment
$33,168K
(-59.88%↓ Y/Y)
Acquisition of businesses,
net of cash acquired...
$1,500K
(-99.41%↓ Y/Y)
Buy us a coffee
GLOBUS MEDICAL INC (GMED)
GLOBUS MEDICAL INC (GMED)